Aptose Biosciences Inc (NAS:APTO)
$ 0.179 0.001 (0.56%) Market Cap: 3.47 Mil Enterprise Value: -4.12 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 27/100

Q1 2019 Aptose Biosciences Inc Earnings Call Transcript

May 07, 2019 / 09:00PM GMT
Release Date Price: $33.45 (-2.19%)
Operator

Good afternoon. My name is Tiffany and I'll be your conference operator today. I would like to welcome everyone to the Aptose Biosciences Conference Call for the First Quarter Ended March 31, 2019. (Operator Instructions) Thank you. As a reminder, this conference call maybe recorded.

I would now like to introduce Ms. Susan Pietropaolo. Please go ahead.

Susan M. Pietropaolo
SMP Communications, Inc. - Principal

Thank you, Tiffany. Good morning and welcome to the Aptose Biosciences conference call to discuss financial and operational results for the first quarter ended March 31, 2019. I am Susan Pietropaolo, Communications Representative for Aptose Biosciences. Joining me on the call today are Dr. William G. Rice, Chairman, President and CEO; and Mr. Gregory Chow, Executive Vice President and Chief Financial Officer.

Before we proceed, I would like to remind everyone that certain statements made during this call will include forward-looking statements within the meaning of U.S. and Canadian Securities Laws. Forward-looking statements reflect

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot